Ameliorative Effect of Oxytocin on FBN1 and PEPCK Gene Expression, and Behavioral Patterns in Rats' Obesity-Induced Diabetes

• Egile Nagusiak: Asmaa Elnagar (Egilea), Khalifa El-Dawy (Egilea), Hussein I. El-Belbasi (Egilea), Ibrahim F. Rehan (Egilea), Hamdy Embark (Egilea), Zeinab Al-Amgad (Egilea), Obeid Shanab (Egilea), Elsayed Mickdam (Egilea), Gaber E. Batiha (Egilea), Salman Alamery (Egilea), Samer S. Fouad (Egilea), Simona Cavalu (Egilea), Mohammed Youssef (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Amelioration of hyperinsulinemia and insulin resistance associated with obesity is a cardinal target for therapeutics. Therefore, we investigated the relation of Fibrilln-1 (FBN1) mRNA expression and hepatic phosphoenolpyruvate caboxykinase (PEPCK) enzyme to the ameliorative impact of oxytocin on ob...